MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617079858 A) filed by Fortvita Biologics Inc. on June 29, 2026, for Glp-1 Receptor Targeting Compounds And Uses Thereof.
Inventors include Xu, Lianhong; Yu, Nan; Ren, Decheng; and Xiong, Yao.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present disclosure relates to compounds of Formula (I), or a pharmaceutically acceptable salt thereof, stereoisomer thereof, analog thereof, solvate thereof, prodrug thereof, and/or tautomer thereof, as well as pharmaceutical compositions including such a compound, wherein the variables are as defined in the specification. Also described are method of using such compounds and pharmaceutical compositions to treat GLP-1 associated diseases, disorders, or conditions.
Disclaimer: Curated by HT Syndication.
